Fuggle, N. R., Beaudart, C., Bruyère, O., Abrahamsen, B., Al-Daghri, N., Burlet, N., Chandran, M., Rosa, M. M., Cortet, B., Demonceau, C., Dere, W., Halbout, P., Hiligsmann, M., Kanis, J. A., Kaufman, J.-M., Kurth, A., Lamy, O., Laslop, A., Maggi, S., ... Harvey, N. C. (14 March 2024). Evidence-Based Guideline for the management of osteoporosis in men. Nature Reviews Rheumatology, 20 (4), 241-251. doi:10.1038/s41584-024-01094-9 |
Beaudart, C., Sharma, M., Clark, P., Fujiwara, S., Adachi, J. D., Messina, O. D., Morin, S. N., Kohlmeier, L. A., Sangan, C. B., Nogues, X., Cruz-Priego, G. A., Cavallo, A., Cooper, F., Grier, J., Leckie, C., Montiel-Ojeda, D., Papaioannou, A., Raskin, N., Yurquina, L., ... Hiligsmann, M. (March 2024). Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study. Osteoporosis International, 35 (3), 451-468. doi:10.1007/s00198-023-06955-9 |
Hiligsmann, M., Silverman, S. L., Singer, A. J., Pearman, L., Wang, Y., Caminis, J., & Reginster, J.-Y. (30 January 2024). Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging Clinical and Experimental Research, 36 (1), 14. doi:10.1007/s40520-023-02682-7 |
Beaudart, C., Tilquin, N., Abramowicz, P., Baptista, F., Peng, D. J., de Souza Orlandi, F., Drey, M., Dzhus, M., Fábrega-Cuadros, R., Fernandez-Garrido, J., Laurindo, L. F., Gasparik, A.-I., Geerinck, A., Emin, G., Iacob, S., Kilaitė, J., Kumar, P., Lee, S.-C., Lou, V. W. Q., ... Bruyère, O. (15 December 2023). Quality of life in sarcopenia measured with the SarQoL questionnaire: A meta-analysis of individual patient data. Maturitas, 180, 107902. doi:10.1016/j.maturitas.2023.107902 |
Moon, R. J., Reginster, J.-Y., Al-Daghri, N., Thiyagarajan, J. A., Beaudart, C., Bruyère, O., Burlet, N., Chandran, M., da Silva, M. C., Conaghan, P. G., Dere, W. H., Diez-Perez, A., Hadji, P., Halbout, P., Hiligsmann, M., Kanis, J. A., McCloskey, E. V., Ormarsdottir, S., Prieto-Alhambra, D., ... Harvey, N. C. (August 2023). Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Osteoporosis International, 34 (8), 1283 - 1299. doi:10.1007/s00198-023-06827-2 |
Hiligsmann, M., Silverman, S. S., Singer, A. J., Pearman, L., Mathew, J., Wang, Y., Caminis, J., & Reginster, J.-Y. (2023). Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. PharmacoEconomics. doi:10.1007/s40273-023-01270-x |
Li, N., Beaudart, C., Cauley, J. A., Ing, S. W., Lane, N. E., Reginster, J.-Y., Silverman, S., Singer, A. J., & Hiligsmann, M. (April 2023). Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics, 41 (4), 363 - 391. doi:10.1007/s40273-022-01239-2 |
Li, N., Beaudart, C., Cauley, J. A., Ing, S. W., Lane, N. E., Reginster, J.-Y., Silverman, S., Singer, A. J., & Hiligsmann, M. (April 2023). Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics, 41 (4), 393. doi:10.1007/s40273-023-01255-w |
Fuggle, N., Al-Daghri, N., Bock, O., Branco, J., Bruyère, O., Casado, E., Cavalier, E., Cortet, B., de Wit, M., Giusti, A., Halbout, P., Harvey, N. C., Hiligsmann, M., Kaufman, J.-M., Kurth, A., Maggi, S., Matijevic, R., Minisola, S., Palacios, S., ... Cooper, C. (03 January 2023). Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging Clinical and Experimental Research, online. doi:10.1007/s40520-022-02319-1 |
Fuggle, N., Bere, N., Bruyère, O., Rosa, M. M., Prieto Yerro, M. C., Dennison, E., Dincer, F., Gabay, C., Haugen, I. K., Herrero-Beaumont, G., Hiligsmann, M., Hochberg, M. C., Laslop, A., Matijevic, R., Maheu, E., Migliore, A., Pelletier, J.-P., Radermecker, R., Rannou, F., ... Reginster, J.-Y. (2022). Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach. Aging Clinical and Experimental Research. doi:10.1007/s40520-022-02176-y |
Chotiyarnwong, P., McCloskey, E. V., Harvey, N., Lorentzon, M., Prieto-Alhambra, D., Abrahamsen, B., Adachi, J. D., Borgström, F., Bruyère, O., Carey, J. J., Clark, P., Cooper, C., Curtis, E. M., Dennison, E., Diaz-Curiel, M., Dimai, H. P., Grigorie, D., Hiligsmann, M., Khashayar, P., ... Kanis, J. A. (2022). Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group. Archives of Osteoporosis, 17 (1), 87. doi:10.1007/s11657-022-01117-6 |
Hiligsmann, M., Silverman, S., Singer, A., Pearman, L., Mathew, J., Wang, Y., Caminis, J., & Reginster, J.-Y. (2022). Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate in US men at imminent risk of fracture. Journal of Managed Care and Specialty Pharmacy, 28, 105. |
Dangouloff, T., Servais, L., & Hiligsmann, M. (2020). SMA: REGISTRIES, BIOMARKERS & OUTCOME MEASURES: P.191 Preliminary data for the cost-effectiveness assessment of the newborn screening for SMA in Belgium. Neuromuscular Disorders. doi:10.1016/j.nmd.2020.08.193 |
Dangouloff, T., Servais, L., & Hiligsmann, M. (2020). SMA: REGISTRIES, BIOMARKERS & OUTCOME MEASURES: P.187 Systematic literature review of the economic burden and economic evaluations in spinal muscular atrophy. Neuromuscular Disorders. doi:10.1016/j.nmd.2020.08.189 |
Leclercq, V., Hiligsmann, M., Parisi, G., Beaudart, C., Tirelli, E., & Bruyère, O. (February 2020). Prioritization of items of the AMSTAR 2 tool to critically appraise systematic reviews and meta-analyses: A best-worst scaling approach [Paper presentation]. REWARD EQUATOR Conference 2020. |
Dangouloff, T., Burghes, A., Bertini, E., BOEMER, F., Hiligsmann, M., Mueller-Felber, W., Tiziano, F. D., Young, P., Germanenko, O., De Lemus, M., Ouillade, L., Rucinski, K., Stephenson, K., Farwell, W., Gorni, K., Hjort, M., Kausar, I., Tizzano, E. F., & Servais, L. (January 2020). 244th ENMC International Workshop: Newborn screening in Spinal Muscular Atrophy May 10-12, 2019, Hoofdorp, The Netherlands. Neuromuscular Disorders, 30 (1), 93-103. doi:10.1016/j.nmd.2019.11.002 |
Dangouloff, T., Hiligsmann, M., CABERG, J.-H., BOEMER, F., & Servais, L. (2018). Development of a decision-analytic model for the economic evaluation of newborn screening for spinal muscular atrophy. Neuromuscular Disorders, 28 (S29–S146), 59. doi:10.1016/j.nmd.2018.06.125 |
Hiligsmann, M., Boonen, A., Rabenda, V., & REGINSTER, J.-Y. (2012). The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Review of Pharmacoeconomics and Outcomes Research, 12 (2), 159-66. doi:10.1586/erp.12.8 |
Hiligsmann, M., & Reginster, J.-Y. (2012). Un monde médical et économique en pleine évolution : maladies complexes et intérêt de l’évaluation économique des technologies de santé. Revue Médicale de Liège, 67 (5-6), 258-262. |
Hiligsmann, M., & Reginster, J.-Y. (2011). Cost effectiveness of denosumab compared with oral bisphosphonates in the treatment of post-menopausal osteoporotic women in Belgium. PharmacoEconomics, 29 (10), 895-911. doi:10.2165/11539980-000000000-00000 |
Johansson, H., Kanis, J. A., McCloskey, E. V., Oden, A., Devogelaer, J. P., Kaufman, J. M., Neuprez, A., Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2011). A FRAX(R) model for the assessment of fracture probability in Belgium. Osteoporosis International, 22 (2), 453-61. doi:10.1007/s00198-010-1218-1 |
Hiligsmann, M. (November 2010). Analyse coût-efficacité des traitements anti-osteoporotiques [Paper presentation]. Colloques cliniques du service des maladies osseuses, Genève, Switzerland. |
Hiligsmann, M. (2010). Evaluation économique de la prise en charge de l'ostéoporose [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/40956 |
Neuprez, A., Johansson, H., Kanis, J., McCloskey, E. V., Oden, A., Bruyère, O., Hiligsmann, M., Devogelaer, J.-P., Kaufmann, J.-M., & Reginster, J.-Y. (December 2009). Rationalisation du remboursement des médicaments de l'ostéoporose : de la mesure isolée de la densité osseuse à l’intégration des facteurs cliniques de risque fracturaire. Validation de l’algorithme FRAX®. Revue Médicale de Liège, 64 (12), 612-619. |
Hiligsmann, M., Rabenda, V., & Reginster, J.-Y. (June 2009). The clinical and economic burden of nonadherence with oral bisphosphonates in osteoporotic patients. Annals of the Rheumatic Diseases, 68 (S3), 667. |
NEUPREZ, A., Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2009). Efficacite anti-fracturaire de l'ibandronate administre par voie intraveineuse: de la complexite des etudes epidemiologiques interventionnelles a la pratique quotidienne. Revue Médicale de Liège, 64 (10), 525-9. |
Reginster, J.-Y., Hiligsmann, M., Rabenda, V., Zegels, B., Neuprez, A., & Bruyère, O. (2009). Ibandronate in the management of postmenopausal osteoporosis. Clinical Medicine. Therapeutics, 1, 1409-1421. |
Bruyère, O., Brandi, M., Vellas, B., Hiligsmann, M., & Reginster, J.-Y. (June 2008). Relationship between long-term changes in femoral neck bone mineral density and hip fracture incidence in untreated postmenopausal osteoporotic women. Annals of the Rheumatic Diseases, 67 (Suppl.II), 403. |
Bruyère, O., Pieck, C., Hiligsmann, M., Zegels, B., Delhez, M., Mottet, C., & Reginster, J.-Y. (June 2008). Place of residence as a risk factor for hip fracture? A case-control 3-year study. Annals of the Rheumatic Diseases, 67 (Suppl.II), 428. |
Hiligsmann, M., Bruyère, O., Pire, G., & Reginster, J.-Y. (2008). Evaluation économique de la campagne de dépistage de l'ostéoporose menée en Province de Liège avec le concours de Liège Province Santé. Revue Médicale de Liège, 63 (10), 588-94. |
Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2008). Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. Revue Médicale de Liège, 63 (7-8), 480-487. |
Neuprez, A., Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (2007). Prevention of hip fractures in osteoporosis. Minerva Ortopedica e Traumatologica, 58 (5), 423-437. |